White House withdraws nomination of Heidi Overton to lead FDA

by | Nov 18, 2026 | Politics

White House withdraws nomination of Heidi Overton to lead FDA

The White House announced the withdrawal of Heidi Overton’s nomination to serve as commissioner of the Food and Drug Administration, according to a White House official. Overton, a physician and prominent abortion opponent, had been nominated in August. She spent much of her career working directly for Trump or conservative organizations supporting his political agenda.

The nomination was initially viewed as an effort to install a loyal Trump appointee to stabilize the agency following a contentious period under Trump’s first FDA commissioner, Marty Makary. However, Overton encountered skeptical questioning from senators across the aisle regarding her willingness to maintain scientific independence from Trump, particularly concerning his assertions about childhood vaccine safety that lack scientific support.

Republican Senator Bill Cassidy of Louisiana, who chairs the Senate health committee, expressed uncertainty about supporting the nomination ahead of a committee vote scheduled for Wednesday. Cassidy had previously characterized Overton’s backing of Trump’s proposal to separate combination vaccines, such as the measles, mumps and rubella shot, as “almost disqualifying.” During a September hearing, he questioned whether Overton would demonstrate scientific independence and resist pressure from Trump and Health Secretary Robert F. Kennedy Jr., a known vaccine skeptic.

As FDA commissioner, Overton would have overseen the agency responsible for regulating medication abortion. In a 2023 policy document for the conservative America First Policy Institute, she advocated for strict congressional regulation of the abortion pill mifepristone and criticized federal policies permitting mail delivery of abortion medications. Reproductive Freedom for All, a reproductive rights organization, stated the withdrawal prevented a threat to medication abortion access.

Confirmation would have required support from all 12 Republicans on the Senate health committee, as Democrats hold 11 seats. Without committee approval, the nomination faced minimal prospects for passage in a full Senate vote. Republicans are working to secure confirmation of Trump’s current nominees before Senate Democrats assume the majority in January.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI